Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous LPS challenge effects on bone marrow immune cells in healthy male volunteers
NL-OMON51456Active, not recruiting
- Sponsor
- Centre for Human Drug Research
- Start
- Sep 2022
- Countries
- 1
01
Overview
Open-label trial of lipopolysaccharide endotoxin (2 arms), sponsored by Centre for Human Drug Research. Primary endpoints: Whole-blood leukocyte differential, Whole-blood flow cytometry and 7 more. Started Sep 2022; status: active, not recruiting.
02
Drugs
lipopolysaccharide endotoxin
Beyond the preview
Go deeper on NL-OMON51456.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON51456.